CXR Atlas

Mediastinum & hila · ESR chapter pp.95–100

Pathology of the hilum

Hilar enlargement is nodal, arterial or bronchial; unilateral vs bilateral and symmetry narrow the differential.

Practise this topic (3 questions)

Differential

  • Unilateral: bronchogenic carcinoma*, lymphadenopathy (nodal metastases), tuberculosis*, lymphoma, sarcoidosis (less often), enlarged pulmonary artery (massive embolus, aneurysm, post-stenotic dilatation).
  • Bilateral: sarcoidosis*, lymphoma, metastases, infection (TB, mycoplasma), silicosis, pulmonary arterial hypertension*. (* = most common causes.)
  • Significant enlargement is needed before a CXR shows it; CT, PET/CT, EBUS, bronchoscopy or mediastinoscopy may be required.

Sarcoidosis

  • Non-caseating granulomatous disease, usually adults 20–40 years, highest incidence in African-Americans and northern Europeans; >90% have chest involvement though ~50% are asymptomatic.
  • CXR: symmetric bilateral hilar “potato nodes” plus right paratracheal nodes (the 1-2-3 sign, also called the pawnbroker’s sign); isolated mediastinal nodes are rare; eggshell calcification in chronic disease.
  • CXR staging: 0 normal; 1 nodes only; 2 nodes + parenchymal disease; 3 parenchymal only; 4 fibrosis. Spontaneous resolution falls from stage 1 (up to ~90%) to stage 4 (0%). CXR stage does not track clinical severity; CT is more sensitive.

Lymphoma and nodal metastases

  • Hodgkin lymphoma more often shows bilateral hilar involvement at presentation than NHL; extra-nodal disease is commoner in NHL.
  • Lung-cancer nodal metastases cause unilateral hilar enlargement ± convex APW; FDG PET/CT shows hypermetabolic nodes.

Images for this topic

11 images